Product Code: ETC4471647 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
Cardiac marker testing has gained prominence in Malaysia due to the rising incidence of cardiovascular diseases. These tests play a crucial role in early diagnosis, risk assessment, and monitoring of heart-related conditions. The market is witnessing growth as healthcare providers prioritize preventative measures, and patients become more conscious of their heart health. Advancements in cardiac biomarker testing methods and technology are driving this market`s expansion.
The Malaysia cardiac marker testing market is expanding primarily because of the rising incidence of cardiovascular diseases in the country. Cardiac markers are essential for the early diagnosis and management of heart-related conditions, and as awareness about heart health increases, the demand for cardiac marker testing is growing. Furthermore, technological advancements in cardiac marker testing techniques, allowing for quicker and more accurate results, are driving market growth. The continuous efforts by healthcare professionals to improve cardiac care further fuel the demand for these tests.
The Malaysia cardiac marker testing market faces multiple challenges, primarily related to the diversity of available cardiac markers and the need for standardization. The market involves various markers used for different cardiac conditions, and ensuring consistent and accurate results across different diagnostic platforms is a significant challenge. Standardizing diagnostic criteria and reference ranges for cardiac markers is essential for proper interpretation and diagnosis. Additionally, the market contends with issues related to reimbursement and insurance coverage for cardiac marker tests, as well as the cost of these tests, which can affect their accessibility. Public awareness about the importance of regular cardiac marker testing and preventive healthcare measures also remains a challenge. Regulatory compliance and adherence to quality standards are vital in ensuring the reliability of cardiac marker tests.
The COVID-19 pandemic has had a multifaceted impact on the Malaysia cardiac marker testing market. On one hand, the heightened focus on respiratory illnesses and the strain on healthcare resources directed attention away from some non-COVID-related diagnostic areas, including cardiac marker testing. However, as the pandemic unfolded, there was a growing recognition of the interplay between COVID-19 and cardiovascular health. This awareness led to increased emphasis on cardiac marker testing as a crucial diagnostic tool, especially in severe COVID-19 cases. Additionally, the pandemic prompted a reevaluation of healthcare priorities, with a renewed emphasis on comprehensive diagnostic capabilities, including cardiac markers, to address both acute and chronic conditions. This shift in perspective is likely to have a lasting impact on the market.
Cardiac marker testing is a critical aspect of cardiovascular disease diagnosis and monitoring in Malaysia. Leading Players in this market include established clinical laboratories and diagnostic companies like Clinical Genomics, Quest Diagnostics, and LabCorp. They offer a comprehensive range of cardiac marker tests, including troponin, creatine kinase-MB, and myoglobin assays. Additionally, public and private hospitals with specialized cardiology departments, such as the National Heart Institute (IJN) and Gleneagles Kuala Lumpur, are significant players, as they provide cardiac marker testing as part of their cardiology services.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Cardiac Marker Testing Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Malaysia Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Malaysia Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Malaysia Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Malaysia Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Malaysia Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Malaysia Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Cardiac Marker Testing Market Trends |
6 Malaysia Cardiac Marker Testing Market, By Types |
6.1 Malaysia Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.4 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Malaysia Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Malaysia Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Malaysia Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Malaysia Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Malaysia Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Malaysia Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Malaysia Cardiac Marker Testing Market Export to Major Countries |
7.2 Malaysia Cardiac Marker Testing Market Imports from Major Countries |
8 Malaysia Cardiac Marker Testing Market Key Performance Indicators |
9 Malaysia Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Malaysia Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Malaysia Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Malaysia Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Malaysia Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Malaysia Cardiac Marker Testing Market - Competitive Landscape |
10.1 Malaysia Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |